Navigation Links
Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes

INDIANAPOLIS and BENTONVILLE, Ark., June 22 /PRNewswire-FirstCall/ -- Walmart (NYSE: WMT) and Eli Lilly and Company (NYSE: LLY) announced today they're teaming up to provide an affordable insulin option for people with diabetes.  

Beginning in mid-September, Lilly's Humulin® brand of insulin will be available in Walmart pharmacies across the U.S. under the dual-branded name Humulin® ReliOn®, including 10 mL vials of Humulin® R U-100, Humulin® N, and Humulin® 70/30 formulations.

Nearly 24 million Americans have diabetes, up from 21 million in 2005, according to the American Diabetes Association. Of those, about a quarter (27 percent) use insulin to manage blood sugar levels.(1)

"With diabetes reaching epidemic proportions in America, it's more important than ever for participants in the healthcare system to work together to provide solutions to help people successfully manage this condition," said Keith Johns, Lilly's senior director for insulins in the U.S. "At Lilly, we strive to provide innovative, cost-effective therapies that help patients manage their diabetes. And as the nation's largest retailer, Walmart touches more consumers than any other retail organization in the country. This collaboration offers a unique opportunity to provide a low-cost therapy to large numbers of people affected by diabetes."

Walmart has been a leader in providing quality, low-cost healthcare products to patients, pioneering and expanding access to affordable medications.

Along with Humulin® ReliOn® insulin, Walmart also offers $9 diabetes management products, including the ReliOn Ultima Blood Glucose Meter, the ReliOn Ultima Blood Glucose Test Strips (20 ct) and the ReliOn A1c test (glycated hemoglobin).

"Our ReliOn diabetes management products offer customers access to quality, affordable products that allow our customers to save money and live better, healthier lives," said Sandy Kinsey, Walmart's Vice President, Pharmacy Merchandising, Health and Wellness. "With this new offering of Humulin ReliOn insulin, Walmart underscores our commitment to helping people affected by diabetes manage their healthcare needs."

Humulin is the world's first synthetic human insulin. Its introduction by Lilly in 1982 revolutionized the treatment of diabetes by providing a biosynthetic version of human insulin, a naturally occurring hormone produced by the pancreas that regulates blood sugar but is diminished or absent in people with diabetes.

Humulin Safety Information

Any change of insulin should be made cautiously and only under medical supervision. Changes in strength, manufacturer, type, species, or method of manufacture may result in the need for a change in dosage.

About Lilly Diabetes

For more than 85 years, Eli Lilly and Company has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy – practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journey of each person living with or treating diabetes inspires ours. For more information, visit

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Information about Lilly is available at

About Walmart

Wal-Mart Stores, Inc. (NYSE: WMT), or "Walmart," serves customers and members more than 200 million times per week at more than 8,400 retail units under 55 different banners in 15 countries. With fiscal year 2010 sales of $405 billion, Walmart employs more than 2 million associates worldwide. A leader in sustainability, corporate philanthropy and employment opportunity, Walmart ranked first among retailers in Fortune Magazine's 2009 Most Admired Companies survey. Additional information about Walmart can be found by visiting and on Twitter at  Online merchandise sales are available at and

Humulin® is a trademark of Eli Lilly and Company.

Other trademarked names mentioned herein are the trademarks of their respective owners.


(1) Centers for Disease Control, National Diabetes Fact Sheet,  


(Logo: )

(Logo: )

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Declares Third-Quarter 2010 Dividend
2. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
3. Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
4. Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux
5. Lillys Online, Interactive Health Education Program Receives Two Web Awards
6. Lilly Reports Fourth-Quarter and Full-Year 2009 Results
7. Lilly Confirms Date and Conference Call For Fourth-Quarter and Full-Year 2009 Financial Results Announcement
8. Lilly CEO Stresses Human Element in Driving Medical Innovation
9. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
10. PDL BioPharma Announces New Licensing Agreement With Eli Lilly
11. Lilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):